Navigation Links
IsoTis Adjourns Special Meeting to October 23, 2007
Date:10/11/2007

seek bankruptcy protection.

About IsoTis

IsoTis is an orthobiologics company that develops, manufactures and markets proprietary products for the treatment of musculoskeletal diseases and disorders. IsoTis' current orthobiologics products are bone graft substitutes that promote the regeneration of bone and are used to repair natural, trauma-related and surgically-created defects common in orthopedic procedures, including spinal fusions. IsoTis' current commercial business is highlighted by its Accell line of products, which the company believes represents the next generation in bone graft substitution.

On August 7, 2007 Integra and IsoTis announced that they have reached a definitive agreement to create a global orthobiologics leader. The combination would create a comprehensive orthobiologics portfolio, one of the largest sales organizations focused on orthobiologics in the US, and multiple cross-selling opportunities. The transaction is subject to approval of IsoTis' stockholders, as well as other closing conditions and approvals. Upon closing, IsoTis will become a wholly-owned subsidiary of Integra and Integra will be one of the largest companies in the world focused on advanced technology in orthobiologics.

Forward-Looking Statements

Certain statements in this press release are "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, including those that refer to management's plans and expectations for, among other things, future operations, strategies, prospects, performance and financial condition and IsoTis' proposed acquisition by Integra. Words such as "strategy," "expects," "plans," "anticipates," "believes," "may," "will," "might," "could," "would," "continues," "estimates," "intends," "pursues," "projects," "goals," "targets" or the negative or other variations thereof and other words of similar meaning are intended to identify such forward-looking statements. One can
'/>"/>

SOURCE IsoTis Inc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Calcium Plus Assay Kit, Superior Detection for Specialized Targets
2. Neurognostics receives special FDA clearance for MindState fDAD
3. Berbee designated a Microsoft Small Business Specialist
4. Special needs addressed at Web Usability Conference
5. OASYS Online Provides Special Education Data Management
6. AG accuses BioCATT of violating meetings law
7. VC trends, company progress discussed at Mason Wells portfolio meeting
8. Beware the Dreaded Off-Site Technology Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 28, 2015 Natera, Inc., a leader ... published in Ultrasound in Obstetrics & Gynecology ... non-invasive prenatal test (NIPT) can identify a complete ... A study based upon data collected in ... in about 1 in 1,000 pregnancies, although other ...
(Date:5/28/2015)... NORTH BRUNSWICK, N.J. , May 28, 2015 ... that PDS0101, a cancer immunotherapy treatment targeting HPV-16, ... patients.  Currently, pre-cervical cancer is ... could offer a simple and effective non-surgical alternative. ... body,s defense mechanisms (T-cells) to recognize, target, and ...
(Date:5/28/2015)... , May 28, 2015  GenVec, Inc. (Nasdaq: ... CEO, Douglas J. Swirsky , will present a ... at 11 a.m. EDT on Thursday, June 4, 2015. ... Mr. Swirsky,s presentation will be available at the following ... available on GenVec,s website.  To access, visit www.genvec.com ...
(Date:5/28/2015)... Glenn Keet, CEO of Clinovo ... EMR/EHR Clinical Data Integration with EDC Systems ” at ... DC on June 14th-18th. , During the presentation, Glenn ... with EDC, and will examine the value of patient ... electronic health records/electronic medical records integration. , The ...
Breaking Biology Technology:First Confirmed Detection of a Complete Molar Pregnancy with Cell-Free DNA Test 2First Confirmed Detection of a Complete Molar Pregnancy with Cell-Free DNA Test 3PDS Biotechnology reports positive Phase I clinical trial results in proprietary HPV-Cancer Immunotherapy 2GenVec To Present At The Jefferies Healthcare Conference 2Clinovo Presents at the DIA 2015 51st Annual Meeting in Washington, DC on June 14th-18th 2
... Researchers at Oregon State University have solved a quest ... the 1960s, and could form the basis of a ... online in the professional journal Advanced Materials, outlines the ... diode. "Researchers have been trying to do this ...
... of FDA inspectors; now it trains thousands of those ... team of FDA compliance experts, EduQuest is presenting the ... course for quality managers and regulatory specialists December 7-9, ... I-95, Amtrak rail lines, and the Philadelphia airport). Course ...
... NEW YORK, Oct. 29 Regenicin, Inc. ... company specializing in the development of regenerative cell therapies ... today announced that the Company,s Chief Executive Officer, Randall ... at RetailInvestorConferences.com .DATE: , November 4, 2010TIME: ...
Cached Biology Technology:Advance could change modern electronics 2Advance could change modern electronics 3Former FDA Inspectors Train Medical Device, Pharmaceutical Companies How to Comply with Latest FDA Expectations for Validation and Part 11 2Regenicin to Present Live at RetailInvestorConferences.com on November 4th 2
(Date:5/20/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... LLC, a company engaged in biometric identification is an ... portion of the recently awarded TIES (Technical Information Engineering ... Army. 3D-ID LLC has a suite of ... and security agencies. Gino Pereira , ...
(Date:5/14/2015)... , May 14, 2015 Research and Markets ... of the "Fingerprint Sensors Market in Smart Mobile ... This report believes that 2014 was a watershed year ... Apple,s introduction of ,Apple Pay,. Apple gave fingerprint sensors ... mobile payment service. Fingerprint sensors are a must-have feature ...
(Date:5/10/2015)... 11, 2015 Fingerprint Cards (FPC) has ... FPC1155 from the distributor World Peace Industrial Group (WPI), part ... Asia . Deliveries are planned to take ... by smartphone manufacturers in China . The ... revenue guidance of + 1 000 MSEK for 2015.   ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2
... May 15, 2008The investigational chemotherapeutic agent eribulin mesylate ... of women with locally advanced or metastatic breast ... II clinical trial. The study also suggests ... with a low incidence of Grade 3 (severe) ...
... 2008 -- There is only one place this summer where the ... and clarinet will be heard next door to advanced sonar systems; ... falls of Antarctic ice shelves. These sounds -- and ... at the Acoustics,08 Paris meeting, to be held Monday June 30 ...
... R.I. [Brown University] Imagine being paralyzed, unable to move ... five million Americans suffer from this debilitating situation. Or imagine ... of Americans are affected by these infirmities. Now imagine ... hands or arms enough to tap out an e-mail on ...
Cached Biology News:Eribulin mesylate demonstrated anti-tumor activity in patients with advanced breast cancer 2Eribulin mesylate demonstrated anti-tumor activity in patients with advanced breast cancer 3Brown to host conference on advances in neurotechnology 2Brown to host conference on advances in neurotechnology 3
Request Info...
Agarose-LE, 250 g. Suitable for soft agarose cloning. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1200 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
IC50: 3 ng/ml · Limit of detection: 0.9 ng/ml...
Request Info...
Biology Products: